Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Widespread Increased Diffusivity Reveals Early Cortical Degeneration in Huntington Disease.

Sampedro F, Martínez-Horta S, Perez-Perez J, Horta-Barba A, Martin-Lahoz J, Alonso-Solís A, Corripio I, Gomez-Anson B, Kulisevsky J.

AJNR Am J Neuroradiol. 2019 Sep;40(9):1464-1468. doi: 10.3174/ajnr.A6168.

PMID:
31467235
2.

Depression as a Risk Factor for Impulse Control Disorders in Parkinson Disease.

Marín-Lahoz J, Sampedro F, Martinez-Horta S, Pagonabarraga J, Kulisevsky J.

Ann Neurol. 2019 Aug 15. doi: 10.1002/ana.25581. [Epub ahead of print]

PMID:
31415102
3.

White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease.

De Paepe AE, Sierpowska J, Garcia-Gorro C, Martinez-Horta S, Perez-Perez J, Kulisevsky J, Rodriguez-Dechicha N, Vaquer I, Subira S, Calopa M, Muñoz E, Santacruz P, Ruiz-Idiago J, Mareca C, de Diego-Balaguer R, Camara E.

Neuroimage Clin. 2019 Jul 30;24:101965. doi: 10.1016/j.nicl.2019.101965. [Epub ahead of print]

4.

Specific patterns of brain alterations underlie distinct clinical profiles in Huntington's disease.

Garcia-Gorro C, Llera A, Martinez-Horta S, Perez-Perez J, Kulisevsky J, Rodriguez-Dechicha N, Vaquer I, Subira S, Calopa M, Muñoz E, Santacruz P, Ruiz-Idiago J, Mareca C, Beckmann CF, de Diego-Balaguer R, Camara E.

Neuroimage Clin. 2019;23:101900. doi: 10.1016/j.nicl.2019.101900. Epub 2019 Jun 15.

5.

Pattern of cortical thinning associated with the BDNF Val66Met polymorphism in Parkinson's disease.

Sampedro F, Marín-Lahoz J, Martínez-Horta S, Pagonabarraga J, Kulisevsky J.

Behav Brain Res. 2019 Oct 17;372:112039. doi: 10.1016/j.bbr.2019.112039. Epub 2019 Jun 13.

PMID:
31202861
6.

Cognitive and behavioral assessment in Parkinson's disease.

Martinez-Horta S, Horta-Barba A, Kulisevsky J.

Expert Rev Neurother. 2019 Jul;19(7):613-622. doi: 10.1080/14737175.2019.1629290. Epub 2019 Jun 17.

PMID:
31180250
7.

Effects of mindfulness training on the default mode network in borderline personality disorder.

Carmona I Farrés C, Elices M, Soler J, Domínguez-Clavé E, Martín-Blanco A, Pomarol-Clotet E, Salvador R, Martinez-Horta S, Pascual JC.

Clin Psychol Psychother. 2019 May 27. doi: 10.1002/cpp.2382. [Epub ahead of print]

PMID:
31132302
8.

Mild cognitive impairment in Parkinson's disease.

Martinez-Horta S, Kulisevsky J.

J Neural Transm (Vienna). 2019 Jul;126(7):897-904. doi: 10.1007/s00702-019-02003-1. Epub 2019 Apr 8. Review.

PMID:
30963293
9.

A divergent breakdown of neurocognitive networks in Parkinson's Disease mild cognitive impairment.

Aracil-Bolaños I, Sampedro F, Marín-Lahoz J, Horta-Barba A, Martínez-Horta S, Botí M, Pérez-Pérez J, Bejr-Kasem H, Pascual-Sedano B, Campolongo A, Izquierdo C, Gironell A, Gómez-Ansón B, Kulisevsky J, Pagonabarraga J.

Hum Brain Mapp. 2019 Aug 1;40(11):3233-3242. doi: 10.1002/hbm.24593. Epub 2019 Apr 1.

PMID:
30938027
10.

Clinical manifestations of homozygote allele carriers in Huntington disease.

Cubo E, Martinez-Horta SI, Santalo FS, Descalls AM, Calvo S, Gil-Polo C, Muñoz I, Llano K, Mariscal N, Diaz D, Gutierrez A, Aguado L, Ramos-Arroyo MA; European HD Network.

Neurology. 2019 Apr 30;92(18):e2101-e2108. doi: 10.1212/WNL.0000000000007147. Epub 2019 Mar 13.

PMID:
30867264
11.

Cortical atrophic-hypometabolic dissociation in the transition from premanifest to early-stage Huntington's disease.

Sampedro F, Martínez-Horta S, Perez-Perez J, Horta-Barba A, Lopez-Mora DA, Camacho V, Fernández-León A, Gomez-Anson B, Carrió I, Kulisevsky J.

Eur J Nucl Med Mol Imaging. 2019 May;46(5):1111-1116. doi: 10.1007/s00259-018-4257-z. Epub 2019 Jan 9.

PMID:
30627816
12.

Reduced gray matter volume in cognitively preserved COMT 158Val/Val Parkinson's disease patients and its association with cognitive decline.

Sampedro F, Marín-Lahoz J, Martínez-Horta S, Pagonabarraga J, Kulisevsky J.

Brain Imaging Behav. 2019 Jan 5. doi: 10.1007/s11682-018-0022-y. [Epub ahead of print]

PMID:
30612340
13.

An active cognitive lifestyle as a potential neuroprotective factor in Huntington's disease.

Garcia-Gorro C, Garau-Rolandi M, Escrichs A, Rodriguez-Dechicha N, Vaquer I, Subira S, Calopa M, Martinez-Horta S, Perez-Perez J, Kulisevsky J, Muñoz E, Santacruz P, Ruiz-Idiago J, Mareca C, de Diego-Balaguer R, Camara E.

Neuropsychologia. 2019 Jan;122:116-124. doi: 10.1016/j.neuropsychologia.2018.10.017. Epub 2018 Oct 26.

PMID:
30563619
14.

Disruption of the default mode network and its intrinsic functional connectivity underlies minor hallucinations in Parkinson's disease.

Bejr-Kasem H, Pagonabarraga J, Martínez-Horta S, Sampedro F, Marín-Lahoz J, Horta-Barba A, Aracil-Bolaños I, Pérez-Pérez J, Ángeles Botí M, Campolongo A, Izquierdo C, Pascual-Sedano B, Gómez-Ansón B, Kulisevsky J.

Mov Disord. 2019 Jan;34(1):78-86. doi: 10.1002/mds.27557. Epub 2018 Dec 10.

PMID:
30536829
15.

Dopaminergic degeneration induces early posterior cortical thinning in Parkinson's disease.

Sampedro F, Marín-Lahoz J, Martínez-Horta S, Pagonabarraga J, Kulisevsky J.

Neurobiol Dis. 2019 Apr;124:29-35. doi: 10.1016/j.nbd.2018.11.001. Epub 2018 Nov 6.

PMID:
30408592
16.

Cortical Thinning Associated with Age and CSF Biomarkers in Early Parkinson's Disease Is Modified by the SNCA rs356181 Polymorphism.

Sampedro F, Marín-Lahoz J, Martínez-Horta S, Pagonabarraga J, Kulisevsky J.

Neurodegener Dis. 2018;18(5-6):233-238. doi: 10.1159/000493103. Epub 2018 Oct 18.

PMID:
30336481
17.

Selection of Reference Regions to Model Neurodegeneration in Huntington Disease by 18F-FDG PET/CT Using Imaging and Clinical Parameters.

López Mora DA, Sampedro F, Camacho V, Fernández A, Fuentes F, Duch J, Pérez-Perez J, Martínez-Horta S, Marín-Lahoz J, Domènech A, Flotats A, Estorch M, Kulisevsky J, Carrió I.

Clin Nucl Med. 2019 Jan;44(1):e1-e5. doi: 10.1097/RLU.0000000000002329.

PMID:
30325816
18.

Parkinson's Disease: Impulsivity Does Not Cause Impulse Control Disorders but Boosts Their Severity.

Marín-Lahoz J, Pagonabarraga J, Martinez-Horta S, Fernandez de Bobadilla R, Pascual-Sedano B, Pérez-Pérez J, Gironell A, Kulisevsky J.

Front Psychiatry. 2018 Sep 28;9:465. doi: 10.3389/fpsyt.2018.00465. eCollection 2018.

19.

The impact of bilingualism on brain structure and function in Huntington's disease.

Martínez-Horta S, Moreu A, Perez-Perez J, Sampedro F, Horta-Barba A, Pagonabarraga J, Gomez-Anson B, Lozano-Martinez GA, Lopez-Mora DA, Camacho V, Fernández-León A, Carrió I, Kulisevsky J.

Parkinsonism Relat Disord. 2019 Mar;60:92-97. doi: 10.1016/j.parkreldis.2018.09.017. Epub 2018 Sep 17.

PMID:
30249427
20.

Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline.

Sampedro F, Marín-Lahoz J, Martínez-Horta S, Pagonabarraga J, Kulisevsky J.

Front Neurol. 2018 May 30;9:394. doi: 10.3389/fneur.2018.00394. eCollection 2018.

21.

Circadian Rhythm, Cognition, and Mood Disorders in Huntington's Disease.

Diago EB, Martínez-Horta S, Lasaosa SS, Alebesque AV, Pérez-Pérez J, Kulisevsky J, Del Val JL.

J Huntingtons Dis. 2018;7(2):193-198. doi: 10.3233/JHD-180291.

PMID:
29843249
22.

Structural and metabolic brain correlates of apathy in Huntington's disease.

Martínez-Horta S, Perez-Perez J, Sampedro F, Pagonabarraga J, Horta-Barba A, Carceller-Sindreu M, Gomez-Anson B, Lozano-Martinez GA, Lopez-Mora DA, Camacho V, Fernández-León A, Carrió I, Kulisevsky J.

Mov Disord. 2018 Jul;33(7):1151-1159. doi: 10.1002/mds.27395. Epub 2018 Apr 20.

PMID:
29676484
23.

Neurocardiovascular pathology in pre-manifest and early-stage Huntington's disease.

Bellosta Diago E, Pérez-Pérez J, Santos Lasaosa S, Viloria Alebesque A, Martínez-Horta S, Kulisevsky J, López Del Val J.

Eur J Neurol. 2018 Jul;25(7):956-962. doi: 10.1111/ene.13630. Epub 2018 Apr 16.

PMID:
29537687
24.

Reduced striato-cortical and inhibitory transcallosal connectivity in the motor circuit of Huntington's disease patients.

Garcia-Gorro C, de Diego-Balaguer R, Martínez-Horta S, Pérez-Pérez J, Kulisevsky J, Rodríguez-Dechicha N, Vaquer I, Subira S, Calopa M, Muñoz E, Santacruz P, Ruiz-Idiago J, Mareca C, Caballol N, Camara E.

Hum Brain Mapp. 2018 Jan;39(1):54-71. doi: 10.1002/hbm.23813. Epub 2017 Oct 8.

PMID:
28990240
25.

Circadian rhythm and autonomic dysfunction in presymptomatic and early Huntington's disease.

Bellosta Diago E, Pérez Pérez J, Santos Lasaosa S, Viloria Alebesque A, Martínez Horta S, Kulisevsky J, López Del Val J.

Parkinsonism Relat Disord. 2017 Nov;44:95-100. doi: 10.1016/j.parkreldis.2017.09.013. Epub 2017 Sep 15.

PMID:
28935191
26.

Development and validation of an alternative version of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS).

Fernández-Bobadilla R, Martínez-Horta S, Marín-Lahoz J, Horta-Barba A, Pagonabarraga J, Kulisevsky J.

Parkinsonism Relat Disord. 2017 Oct;43:73-77. doi: 10.1016/j.parkreldis.2017.07.015. Epub 2017 Jul 19.

PMID:
28754233
27.

Important but not Enough - Information about HD Related Topics and Peer and Professional Support for Young Adults from HD Families.

Braisch U, Martinez-Horta S, MacDonald M, Orth M.

J Huntingtons Dis. 2016 Dec 15;5(4):379-387.

PMID:
27983563
28.

Non-demented Parkinson's disease patients with apathy show decreased grey matter volume in key executive and reward-related nodes.

Martinez-Horta S, Sampedro F, Pagonabarraga J, Fernandez-Bobadilla R, Marin-Lahoz J, Riba J, Kulisevsky J.

Brain Imaging Behav. 2017 Oct;11(5):1334-1342. doi: 10.1007/s11682-016-9607-5.

PMID:
27730477
29.

Corrigendum to "Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's disease" [Parkinsonism Relat. Disord. 25C (2016) 58-64].

Martinez-Horta S, Perez-Perez J, van Duijn E, Fernandez-Bobadilla R, Carceller M, Pagonabarraga J, Pascual-Sedano B, Campolongo A, Ruiz-Idiago J, Sampedro F, Landwehrmeyer GB; Spanish REGISTRY investigators of the European Huntington's Disease Network, Kulisevsky J.

Parkinsonism Relat Disord. 2016 Oct;31:161. doi: 10.1016/j.parkreldis.2016.08.011. Epub 2016 Aug 25. No abstract available.

PMID:
27567724
30.

Clinical manifestations of intermediate allele carriers in Huntington disease.

Cubo E, Ramos-Arroyo MA, Martinez-Horta S, Martínez-Descalls A, Calvo S, Gil-Polo C; European HD Network.

Neurology. 2016 Aug 9;87(6):571-8. doi: 10.1212/WNL.0000000000002944. Epub 2016 Jul 8.

PMID:
27402890
31.

Striatal hypometabolism in premanifest and manifest Huntington's disease patients.

López-Mora DA, Camacho V, Pérez-Pérez J, Martínez-Horta S, Fernández A, Sampedro F, Montes A, Lozano-Martínez GA, Gómez-Anson B, Kulisevsky J, Carrió I.

Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2183-2189. Epub 2016 Jun 28.

PMID:
27349245
32.

Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.

Martinez-Horta S, Perez-Perez J, van Duijn E, Fernandez-Bobadilla R, Carceller M, Pagonabarraga J, Pascual-Sedano B, Campolongo A, Ruiz-Idiago J, Sampedro F, Landwehrmeyer GB; Spanish REGISTRY investigators of the European Huntington's Disease Network, Kulisevsky J.

Parkinsonism Relat Disord. 2016 Apr;25:58-64. doi: 10.1016/j.parkreldis.2016.02.008. Epub 2016 Feb 11. Erratum in: Parkinsonism Relat Disord. 2016 Oct;31:161.

PMID:
26898966
33.

Parkinson's Disease--Cognitive Functional Rating Scale across different conditions and degrees of cognitive impairment.

Ruzafa-Valiente E, Fernández-Bobadilla R, García-Sánchez C, Pagonabarraga J, Martínez-Horta S, Kulisevsky J.

J Neurol Sci. 2016 Feb 15;361:66-71. doi: 10.1016/j.jns.2015.12.018. Epub 2015 Dec 11.

PMID:
26810519
34.

Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase.

Pagonabarraga J, Martinez-Horta S, Fernández de Bobadilla R, Pérez J, Ribosa-Nogué R, Marín J, Pascual-Sedano B, García C, Gironell A, Kulisevsky J.

Mov Disord. 2016 Jan;31(1):45-52. doi: 10.1002/mds.26432. Epub 2015 Sep 26. Erratum in: Mov Disord. 2016 Mar;31(3):433.

PMID:
26408291
35.

Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis.

López-Góngora M, Escartín A, Martínez-Horta S, Fernández-Bobadilla R, Querol L, Romero S, Mañanas MÀ, Riba J.

PLoS One. 2015 Aug 31;10(8):e0136786. doi: 10.1371/journal.pone.0136786. eCollection 2015.

36.

Head-to-Head Comparison of the Neuropsychiatric Effect of Dopamine Agonists in Parkinson's Disease: A Prospective, Cross-Sectional Study in Non-demented Patients.

Pérez-Pérez J, Pagonabarraga J, Martínez-Horta S, Fernández-Bobadilla R, Sierra S, Pascual-Sedano B, Gironell A, Kulisevsky J.

Drugs Aging. 2015 May;32(5):401-7. doi: 10.1007/s40266-015-0264-y.

PMID:
25941103
37.

Telling true from false: cannabis users show increased susceptibility to false memories.

Riba J, Valle M, Sampedro F, Rodríguez-Pujadas A, Martínez-Horta S, Kulisevsky J, Rodríguez-Fornells A.

Mol Psychiatry. 2015 Jun;20(6):772-7. doi: 10.1038/mp.2015.36. Epub 2015 Mar 31.

38.

Alterations in cerebral white matter and neuropsychology in patients with cirrhosis and falls.

Gómez-Ansón B, Román E, Fernández de Bobadilla R, Pires-Encuentra P, Díaz-Manera J, Núñez F, Martinez-Horta S, Vives-Gilabert Y, Pagonabarraga J, Kulisevsky J, Cordoba J, Guarner C, Soriano G.

PLoS One. 2015 Mar 20;10(3):e0118930. doi: 10.1371/journal.pone.0118930. eCollection 2015.

39.

Rasagiline for the treatment of parkinsonism in Huntington's disease.

Pérez-Pérez J, Martínez-Horta S, Pagonabarraga J, Carceller M, Kulisevsky J.

Parkinsonism Relat Disord. 2015 Mar;21(3):340-2. doi: 10.1016/j.parkreldis.2015.01.002. Epub 2015 Jan 10. No abstract available.

PMID:
25601128
40.

Apathy in Parkinson's disease: neurophysiological evidence of impaired incentive processing.

Martínez-Horta S, Riba J, de Bobadilla RF, Pagonabarraga J, Pascual-Sedano B, Antonijoan RM, Romero S, Mañanas MÀ, García-Sanchez C, Kulisevsky J.

J Neurosci. 2014 Apr 23;34(17):5918-26. doi: 10.1523/JNEUROSCI.0251-14.2014.

41.

Transcranial direct current stimulation of the cerebellum in essential tremor: a controlled study.

Gironell A, Martínez-Horta S, Aguilar S, Torres V, Pagonabarraga J, Pascual-Sedano B, Ribosa-Nogué R.

Brain Stimul. 2014 May-Jun;7(3):491-2. doi: 10.1016/j.brs.2014.02.001. Epub 2014 Feb 6. No abstract available.

PMID:
24582371
42.

Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.

Fernández de Bobadilla R, Pagonabarraga J, Martínez-Horta S, Pascual-Sedano B, Campolongo A, Kulisevsky J.

Mov Disord. 2013 Sep;28(10):1376-83. doi: 10.1002/mds.25568. Epub 2013 Jul 19.

PMID:
23873810
43.

Measuring functional impact of cognitive impairment: validation of the Parkinson's disease cognitive functional rating scale.

Kulisevsky J, Fernández de Bobadilla R, Pagonabarraga J, Martínez-Horta S, Campolongo A, García-Sánchez C, Pascual-Sedano B, Ribosa-Nogué R, Villa-Bonomo C.

Parkinsonism Relat Disord. 2013 Sep;19(9):812-7. doi: 10.1016/j.parkreldis.2013.05.007. Epub 2013 Jun 15.

PMID:
23773412
44.

Apathy in Parkinson's disease: more than just executive dysfunction.

Martínez-Horta S, Pagonabarraga J, Fernández de Bobadilla R, García-Sanchez C, Kulisevsky J.

J Int Neuropsychol Soc. 2013 May;19(5):571-82. doi: 10.1017/S1355617713000131. Epub 2013 Feb 21.

PMID:
23425620
45.

Short-lasting episodes of prosopagnosia in Parkinson's disease.

Villa-Bonomo C, Pagonabarraga J, Martínez-Horta S, Fernandez de Bobadilla R, Garcia-Sanchez C, Campolongo A, Kulisevsky J.

Parkinsonism Relat Disord. 2013 Mar;19(3):375-7. doi: 10.1016/j.parkreldis.2012.11.010. Epub 2012 Dec 11.

PMID:
23238069
46.

Is all cognitive impairment in Parkinson's disease "mild cognitive impairment"?

Martínez-Horta S, Kulisevsky J.

J Neural Transm (Vienna). 2011 Aug;118(8):1185-90. doi: 10.1007/s00702-011-0675-9. Epub 2011 Jun 22. Review.

PMID:
21695418

Supplemental Content

Loading ...
Support Center